Structure-based discovery of positive allosteric modulators of the A 1 adenosine receptor
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2421687122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Anh T N Nguyen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia. Hauptthemen laut MEDLINE: Receptor, Adenosine A1, Drug Discovery, Adenosine A1 Receptor Agonists. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia (Heart Foundation), Federal Government | DHAC | National Health and Medical Research Council (NHMRC), Federal Government | Department of Health and Aged Care, Australian Government (DHAC).
Abstract (Originalsprache)
Allosteric modulation of G protein–coupled receptors (GPCRs) is an exciting strategy for developing new therapeutic agents, and it has several advantages over more commonly used orthosteric drugs. Recently determined GPCR structures have revealed allosteric pockets facing the lipid bilayer, enabling rational drug design. Here, we develop a virtual screening strategy to discover ligands of extrahelical binding pockets and apply this approach to the adenosine A 1 receptor (A 1 R). The A 1 R is a high-value therapeutic target for ischemia–reperfusion injury and chronic neuropathic pain. Developing effective A 1 R therapeutics remains challenging due to high structural conservation across orthosteric binding sites and on-target unwanted effects stimulated by prototypical A 1 R agonists, such as bradycardia and atrioventricular block. However, A 1 R positive allosteric modulators (PAMs) acting through spatially distinct allosteric sites can fine-tune A 1 R activity with high subtype selectivity and spatiotemporal specificity, thereby overcoming current limitations. A chemical library of 160 million compounds was computationally docked to the allosteric pocket identified in a cryo-EM structure of the A 1 R, and a set of 26 top-ranked compounds were selected for experimental evaluation. Pharmacological evaluation of these, and structure-guided hit optimization, led to the discovery of subtype-selective A 1 R PAMs. These compounds demonstrated minimal allosteric agonism and negligible impact on A 1 R-mediated beat rate of an orthosteric agonist. The discovered PAMs pave the way for potential treatments for neuropathic pain and ischemia–reperfusion injury without accompanying side effects. Our results demonstrate the utility of a synergistic computational and experimental approach in GPCR drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
- Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala SE-751 24, Sweden.
- Department of Chemistry-Biomedical Centre (BMC), Uppsala University, Uppsala SE-75123, Sweden.
- Medicinal Chemistry Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
- Australian Research Council Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
ORCID-Profile: Nicolas Panel, Cam Sinh Lu, Shane D Hellyer, Monica Langiu, Manuela Jörg, Karen J Gregory, Paul J White, Arthur Christopoulos, Jens Carlsson, Lauren T May
Förderung
- National Heart Foundation of Australia (Heart Foundation)
- Federal Government | DHAC | National Health and Medical Research Council (NHMRC)
- Federal Government | Department of Health and Aged Care, Australian Government (DHAC)
- Department of Education and Training | Australian Research Council (ARC)
- Swedish Research Council
- Olle Engkvist foundation
Zitieren
APA
Nguyen, A. T. N., Panel, N., Vo, D. D., Thai, B. S., Chia, L. Y., Lu, C. S., Hellyer, S. D., Langiu, M., Jörg, M., Gregory, K. J., Kihlberg, J., White, P. J., Scammells, P. J., Christopoulos, A., Carlsson, J., & May, L. T. (2025). Structure-based discovery of positive allosteric modulators of the A 1 adenosine receptor. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2421687122
Vancouver
Nguyen ATN, Panel N, Vo DD, Thai BS, Chia LY, Lu CS, et al. Structure-based discovery of positive allosteric modulators of the A 1 adenosine receptor. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2421687122
BibTeX
@article{Nguyen2025,
author = {Nguyen, Anh T N and Panel, Nicolas and Vo, Duc Duy and Thai, Bui San and Chia, Ling Yeong and Lu, Cam Sinh and Hellyer, Shane D and Langiu, Monica and Jörg, Manuela and Gregory, Karen J and Kihlberg, Jan and White, Paul J and Scammells, Peter J and Christopoulos, Arthur and Carlsson, Jens and May, Lauren T},
title = {Structure-based discovery of positive allosteric modulators of the A 1 adenosine receptor},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2421687122}
}
EUVIMED